Genetically mofidied stem cells: Can we improve stem cell replacement therapies?

转基因干细胞：我们可以改进干细胞替代疗法吗？

• 批准号: 8148579
• 负责人: Cristina Backman
• 金额: $ 79.85万
• 依托单位: NATIONAL INSTITUTE ON DRUG ABUSE
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8148579
• 关键词: Replacement Therapy; Stem cells; improved

To investigate if the use of genetically modified iPS cells can get around some of the logistical problems imposed by the use of fetal cell transplants, we propose to study if it is possible to manipulate the mechanisms of dopamine-neuronal differentiation and survival in our favor, to generate transformed ES and iPS cells that enhance their therapeutic value when transplanted into the brain of hemiparkinsonian mice. Genetically altered mouse ES and iPS cell lines will be generated by using mouse colonies with specific mutations known to affect the function of dopamine cells. For example, in a previous study we have shown ablation of the gene PTEN (phosphatase and tensin homolog) in dopamine neurons, leads to dopamine hypertrophic effects and a significant increase in neuronal protection. We will generate mouse ES and iPS cells from an established transgenic mouse colony genetically manipulated to ablate PTEN activity in dopamine neurons. Differentiated dopamine cells lacking PTEN activity will be transplanted in the brain of hemiparkinsonian mice to study the benefits of such strategies for dopamine enrichment and survival from transplanted cells and replacement of dopaminergic function.

为了调查使用遗传改性的IPS细胞是否可以通过使用胎儿细胞移植引起的一些后勤问题，我们建议研究是否有可能操纵多巴胺 - 神经元分化和对我们有利的生存机制，以使我们的ES和IPS细胞在转化的转化脑中的脑中脑化脑中的脑脑中升高时会增强脑膜化的脑膜化。通过使用具有特定突变的小鼠菌落来影响多巴胺细胞功能，将产生遗传上改变的小鼠ES和IPS细胞系。例如，在先前的研究中，我们显示了多巴胺神经元中基因PTEN（磷酸酶和tensin同源物）的消融，从而导致多巴胺肥大作用并显着增加神经元保护。我们将从已建立的转基因小鼠菌落中生成小鼠ES和IPS细胞，该菌落在多巴胺神经元中植物植物的遗传操纵。缺乏PTEN活性的分化多巴胺细胞将在Hemiparkinsonian小鼠的大脑中移植，以研究此类策略对多巴胺富集的益处和移植细胞的存活以及多巴胺能功能的替代。